Back to results
US 2017/0360718 A1Published application
Intranasal dental anesthetic
AssigneeSt. Renatus, LLC
InventorMark D. Kollar
Life of this patent
Estimating the term…
Abstract
The present invention relates to intranasally administered pharmaceutical compositions administered for use in anesthesia. Such pharmaceutical compositions comprise benzyl alcohol. The invention also relates to methods for anesthetizing the maxillary dental arch using these pharmaceutical compositions.
Claims34
A method for anesthetizing at least a portion of a patient's maxillary dental arch of a subject comprising administering to said subject an intranasal pharmaceutical composition comprising:
- a) benzyl alcohol;
- and
- b) a pharmaceutically acceptable carrier,
- wherein benzyl alcohol is the sole active agent in said intranasal pharmaceutical composition.
1 more element
The method of claim 11, wherein said viscosity enhancing agent is hydroxyethylcellulose.
Dependencies are inferred from the claim text.